HHS Backs DEA's Effort To Classify Synthetic Kratom Extracts 7-OH And MGPI

HHS Backs DEA's Effort To Classify Synthetic Kratom Extracts 7-OH And MGPI The recommendation would make 7-hydroxymitragynine and mitragynine pseudoindoxyl (MGPI) Schedule I drugs if either compound or a combination of both exceeds “1 milligram per gram in solid powders, encapsulated material, or other solid forms, or exceeds 1 milligram per milliliter in liquid preparations.” Plus, hospitals again are asking the courts to block the 340B rebate program. https://kffhealthnews.org/morning-breakout/administration-news-101326/